Citius Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Citius Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CTXR | Citius Pharma | -$1.72 | -$0.24 | — | — | $0.00 | $5.76M | — | — | 12/26/2025 | |
CTXR | Citius Pharma | -$1.57 | -$0.21 | -$0.80 | -280.95% | $0.00 | $1.92M | $0.00 | -100.00% | 08/12/2025 | |
CTXR | Citius Pharma | -$1.25 | $1.30 | -$1.27 | -197.69% | $0.00 | — | $0.00 | — | 05/14/2025 | |
CTXR | Citius Pharma | -$1.50 | -$1.25 | -$1.30 | -4.00% | $0.00 | — | $0.00 | — | 02/14/2025 | |
CTXR | Citius Pharma | -$1.75 | -$2.00 | -$1.72 | 14.00% | $0.00 | — | $0.00 | — | 12/27/2024 | |
CTXR | Citius Pharma | -$1.50 | -$1.50 | -$1.50 | 0.00% | $0.00 | — | $0.00 | — | 08/12/2024 | |
CTXR | Citius Pharma | -$1.75 | -$1.25 | -$1.25 | 0.00% | $0.00 | — | $0.00 | — | 05/14/2024 | |
CTXR | Citius Pharma | -$0.50 | — | -$1.50 | — | $0.00 | — | $0.00 | — | 02/14/2024 | |
CTXR | Citius Pharma | -$1.25 | — | -$1.75 | — | $0.00 | — | $0.00 | — | 12/29/2023 | |
CTXR | Citius Pharma | -$1.50 | — | -$1.50 | — | $0.00 | — | $0.00 | — | 08/14/2023 | |
CTXR | Citius Pharma | -$1.25 | -$0.75 | -$1.75 | -133.33% | $0.00 | — | $0.00 | — | 05/12/2023 | |
CTXR | Citius Pharma | -$1.50 | — | -$0.50 | — | $0.00 | — | $0.00 | — | 02/10/2023 | |
CTXR | Citius Pharma | -$0.75 | -$1.00 | -$1.25 | -25.00% | $0.00 | — | $0.00 | — | 12/22/2022 | |
CTXR | Citius Pharma | -$1.25 | -$1.25 | -$1.50 | -20.00% | $0.00 | — | $0.00 | — | 08/11/2022 | |
CTXR | Citius Pharma | -$1.00 | — | -$1.25 | — | $0.00 | — | $0.00 | — | 05/12/2022 | |
CTXR | Citius Pharma | -$3.75 | -$1.50 | -$1.50 | 0.00% | $0.00 | — | $0.00 | — | 02/10/2022 | |
CTXR | Citius Pharma | -$1.75 | -$1.00 | -$0.75 | 25.00% | $0.00 | — | $0.00 | — | 12/15/2021 | |
CTXR | Citius Pharma | -$2.75 | -$1.50 | -$1.25 | 16.67% | $0.00 | — | $0.00 | — | 08/12/2021 | |
CTXR | Citius Pharma | -$3.25 | -$1.50 | -$1.00 | 33.33% | $0.00 | — | $0.00 | — | 05/13/2021 | |
CTXR | Citius Pharma | -$3.75 | — | -$3.75 | — | $0.00 | — | $0.00 | — | 02/11/2021 | |
CTXR | Citius Pharma | — | — | -$1.75 | — | — | — | $0.00 | — | 12/16/2020 |
Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
---|---|---|---|---|
Q3 | 2025-08-12 | $-0.80 | $-0.21 | -280.9 % |
Q2 | 2025-05-14 | $-1.27 | $1.30 | -197.7 % |
Q1 | 2025-02-14 | $-1.30 | $-1.25 | -4.00 % |
Q4 | 2024-12-27 | $-1.72 | $-2.00 | 14.0 % |
Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
---|---|---|---|---|
Q3 | 2025-08-12 | $0 | $1.92M | -100.0 % |
Está previsto que Citius Pharmaceuticals (CTXR) presente resultados el diciembre 26, 2025. Los últimos resultados se publicaron el agosto 12, 2025 para el Q3.
El BPA real fue de $-0.80, que no alcanzó la estimación de $-0.21.
Los ingresos reales fueron $0K, que no alcanzó la estimación de $1.9M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.